Federal Funding Opportunities February 27th-March 3rd, 2023
NIH:
- Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)(PAR-23-099)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): Not Applicable
- Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)(PAR-23-106)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): Not Applicable
- Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed)(RFA-ES-23-003)National Institute of Environmental Health SciencesApplication Receipt Date(s): Multiple dates, see announcement.
- Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional(RFA-FD-23-026)Food and Drug AdministrationApplication Receipt Date(s): April 26, 2023
- Dissemination and Implementation of Equity-Focused Evidence-Based Interventions in Healthcare Delivery Systems (R18)(RFA-HS-23-002)Agency for Healthcare Research and QualityApplication Receipt Date(s): April 22, 2023
- Supporting the Management of Substance Use Disorders in Primary Care and other Ambulatory Settings (R18)(RFA-HS-23-005)Agency for Healthcare Research and QualityApplication Receipt Date(s): April 15, 2023
- AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01)(RFA-HS-23-010)Agency for Healthcare Research and QualityApplication Receipt Date(s): April 19, 2023
- AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Preventions (R18)(RFA-HS-23-011)Agency for Healthcare Research and QualityApplication Receipt Date(s): April 19, 2023
- Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 – Clinical Trial Optional)(RFA-MD-23-004)National Institute on Minority Health and Health DisparitiesOffice of Disease PreventionApplication Receipt Date(s): August 09, 2023
- HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)(RFA-NS-24-018)National Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Cancer InstituteNational Eye InstituteNational Heart, Lung, and Blood InstituteNational Institute on AgingNational Institute on Alcohol Abuse and AlcoholismEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): October 23, 2023